Close Window

Digital Look Email A Friend

FDA gives AstraZeneca extension on cancer drug application

Published by Frank Prenesti on 15th December 2022

(Sharecast News) - The US Food and Drug Administration has given AstraZeneca and MSD a three month extension to review a new drug application for its prostate cancer treatment Lynparza.

URL: http://www.digitallook.com/dl/news/story/33180576/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.